相关实验视频
Updated: May 21, 2026

10:28
Body Composition and Metabolic Caging Analysis in High Fat Fed Mice
Published on: May 24, 2018
饮食成分对减肥维护期间的能量消耗的影响
Cara B Ebbeling1, Janis F Swain, Henry A Feldman
1New Balance Foundation Obesity Prevention Center, Children's Hospital Boston, 300 Longwood Ave, Boston, MA 02115, USA.
JAMA
|June 28, 2012
概括
减肥的维护是具有挑战性的,因为减少了能源消耗. 在超重的成年人中,与低脂肪或低血糖指数饮食相比,非常低碳水化合物饮食可以最大限度地减少这种减少.
科学领域:
- 代谢健康 代谢健康
- 营养科学 营养科学
- 肥胖问题研究研究
背景情况:
- 减轻减肥后的能源消耗是重量恢复的一个关键因素.
- 饮食成分对维持体重期间的能量消耗的影响尚不清楚.
研究的目的:
- 研究三种不同宏观营养成分和血糖负载的饮食如何影响减肥后的能量消耗.
- 为了比较低脂肪,低血糖指数和非常低碳水化合物饮食对体重维持期间代谢参数的影响.
主要方法:
- 对21名超重/肥胖成年人进行的受控三方交叉研究.
- 参与者实现了10-15%的体重减轻,然后每人4周食用同热量饮食 (低脂肪,低血糖指数,非常低碳水化合物).
- 主要结果:静止能量消耗 (REE);次要结果:总能量消耗 (TEE),荷尔蒙,代谢综合征的组成部分.
主要成果:
- 在低脂肪饮食中,REE和TEE的减少最大,在低碳水化合物饮食中最小.
- 一个显著的趋势表明,较低的血糖负荷饮食导致能源支出减少较小.
- 激素水平和代谢综合征成分因饮食而异,但没有出现一致的有利模式.
结论:
- 在减肥后,与低脂肪和低血糖指数饮食相比,非常低碳水化合物饮食导致能源消耗减少最少.
- 饮食成分显著影响体重维持期间的能量消耗.
- 这些发现表明,宏观营养素的组成在防止重量恢复方面起着至关重要的作用.
相关概念视频
Energy Balance
The human body gets energy from the three macronutrients: carbohydrates, proteins, and fats. Energy is released when the chemical bonds in the organic compounds present in the food are broken down. The energy content of food is measured in kilocalories (kcal), defined as the amount of heat required to raise the temperature of one kilogram of water by one degree Celsius. This value is determined by measuring the temperature change of the water surrounding a calorimeter after the complete...
Regulation of Food Intake
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Metabolic States of the Body: The Postabsorptive State
The postabsorptive state usually starts about four hours after a meal and lasts until the next meal is eaten. During this time, the digestive system stops absorbing nutrients, and the body uses stored energy reserves to maintain stable blood glucose levels.
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

